RIGEL PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2024.
  • Rigel Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2024 was $41.3M, a 26.5% increase year-over-year.
  • Rigel Pharmaceuticals Inc Costs and Expenses for the twelve months ending September 30, 2024 was $148M, a 3.13% decline year-over-year.
  • Rigel Pharmaceuticals Inc annual Costs and Expenses for 2023 was $137M, a 21.9% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Costs and Expenses for 2022 was $176M, a 8.69% increase from 2021.
  • Rigel Pharmaceuticals Inc annual Costs and Expenses for 2021 was $162M, a 17.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $148M $41.3M +$8.65M +26.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $139M $36.4M +$4.24M +13.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $135M $36.5M -$2.3M -5.92% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $137M $33.8M -$15.4M -31.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $153M $32.6M -$8.21M -20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $161M $32.2M -$10.6M -24.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $172M $38.8M -$4.2M -9.77% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $176M $49.2M +$7.37M +17.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $168M $40.8M -$515K -1.25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $169M $42.8M +$3.47M +8.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $165M $43M +$3.73M +9.51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $162M $41.8M +$4.55M +12.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $157M $41.3M +$9.16M +28.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $148M $39.3M +$5.9M +17.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $142M $39.3M +$4.53M +13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $138M $37.3M +$4.54M +13.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $133M $32.2M -$724K -2.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $134M $33.4M +$1.67M +5.25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $132M $34.7M +$3.73M +12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $128M $32.7M -$2.59M -7.33% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $131M $32.9M +$3.66M +12.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $127M $31.7M +$3.85M +13.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $123M $31M +$6.27M +25.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $117M $35.3M +$9.11M +34.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 $108M $29.2M +$10.5M +55.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $97.6M $27.9M +$8.55M +44.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $89M $24.7M +$4.95M +25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $84.1M $26.2M +$7.43M +39.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $76.7M $18.8M -$7.74M -29.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $84.4M $19.3M -$2.9M -13% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $87.3M $19.8M -$2.81M -12.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $90.1M $18.8M -$2.5M -11.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $92.6M $26.5M +$6.72M +34% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $85.9M $22.2M +$3.08M +16.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $82.8M $22.6M +$2.18M +10.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $80.6M $21.3M -$9.33M -30.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $90M $19.8M -$1.26M -6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $91.2M $19.2M -$6.3M -24.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $97.5M $20.4M -$1.97M -8.78% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $99.5M $30.6M +$7.92M +34.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-07
Q3 2014 $91.6M $21M -$2.89M -12.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $94.5M $25.5M +$1.17M +4.82% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $93.3M $22.4M -$3.33M -12.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $96.6M $22.7M -$2.92M -11.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 $99.5M $23.9M -$1.64M -6.41% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $101M $24.3M -$2.1M -7.95% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $103M $25.7M +$1.65M +6.86% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $102M $25.6M -$294K -1.14% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $102M $25.6M +$3.17M +14.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $98.7M $26.4M +$4.43M +20.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $94.3M $24.1M +$3.2M +15.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $91.1M $25.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 $22.4M +$472K +2.15% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $22M -$527K -2.34% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $20.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q3 2010 $21.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 $22.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.